A drug maker is paying $32 million to settle allegations it violated kickback laws by paying Medicare beneficiary co-pays to encourage the buying of its drug, Oxervate. Dompé U.S. Inc., based in California, has agreed to settle the allegations that …
Source: Claims Journal